Adverse side effects of conventional chemotherapy, acquired resistance and fatal tumor metastasis of human colorectal cancer (CRC) are propelling the exploration for novel selective anticarcinogens. Solasodine is a main active component isolated from Solanum incanum L that exhibited a potent stemness and invasion inhibitory effect on human colorectal cancer HCT116 cells. Colony Spheroid formation assay showed that solasodine dose-dependently prohibited HCT116 cell stemness. CD133, CD44, Nanog, Oct-4 and Sox-2 were inhibited by solasodine to reverse stemness and similar mechanism was stimulated in vivo. Transwell and scratch wound assays revealed that solasodine impeded HCT116 cell invasion and migration potential strengthened by TGF-β1. Moreover, solasodine attenuated TGF-β1-induced EMT and decreased MMPs while in vivo study showed the same trend. The results of this study implied that solasodine may be a novel therapeutic drug for CRC treatment.
Solasodine reverses stemness and epithelial-mesenchymal transition in human colorectal cancer.
Yuwen Zhuang,Cunen Wu,Jin-Yong Zhou,Zhi-ming Zhao,Chun-Li Liu,Junyi Shen,Hui Cai,Shen-Lin Liu
Published 2018 in Biochemical and Biophysical Research Communications - BBRC
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Biochemical and Biophysical Research Communications - BBRC
- Publication date
2018-10-01
- Fields of study
Biology, Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-46 of 46 references · Page 1 of 1
CITED BY
Showing 1-24 of 24 citing papers · Page 1 of 1